Highlights N4 Pharma Plc

Equities

Market Closed - London S.E. Other stock markets 16:35:23 21/05/2024 BST			5-day change	1st Jan Change
0.75 ^GBX	-6.25%		-6.25%	-11.76%

04-25	N4 Pharma strikes partnership deal for intracellular delivery	AN
04-23	N4 Pharma loss widens but "great optimism" remains	AN

N4 Pharma strikes partnership deal for intracellular delivery	04-25	AN
N4 Pharma loss widens but "great optimism" remains	04-23	AN
N4 Pharma Plc Reports Earnings Results for the Full Year Ended December 31, 2023	04-23	CI
N4 Pharma sees potential in Nuvec delivery method for cancer treatment	04-18	AN
N4 Pharma’s In Vivo Testing Shows Nuvec’s Potential as Oral Delivery System	04-18	MT
N4 Pharma shares rise on "encouraging" Nuvec research	02-15	AN
AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets	02-15	AN
N4 Pharma plc Provides In-Vitro siRNA Update	02-15	CI
N4 Pharma's Nuvec Granted Patent in India	01-19	MT
N4 Pharma gets India patent for medical delivery system	01-19	AN
N4 Pharma touts contract to test glaucoma treatment, ECP105	01-16	AN
N4 Pharma hails increased efficacy of Nuvec when complexed with AAV8	01-08	AN
N4 Pharma plc Provides A Further Successful Update on Its Ongoing Research Work into the Use of Nuvec to Enhance the Performance of Viral Vector	01-08	CI
N4 Pharma Plc Provides Positive Update on its Ongoing Oral Delivery Research Work	12-18	CI
N4 Pharma hails "encouraging" siRNA research	12-07	AN
N4 launches investor hub; Capricorn production falls	12-01	AN
N4 Pharma shares fall as places shares to fund Nanogenics stake buy	28/09/23	AN
N4 Pharma Buys 71% Stake in Biotechnology Company Nanogenics; Stock Plummets	28/09/23	MT
N4 Pharma interim loss narrows slightly as business outreach ongoing	12/09/23	AN
Earnings Flash (N4P.L) N4 PHARMA Posts H1 Loss GBX-0.28	12/09/23	MT

No results for this search